NO20044995L - Heterosykliske forbindelser - Google Patents

Heterosykliske forbindelser

Info

Publication number: NO20044995L
Authority: NO; Norway
Prior art keywords: heterocyclic compounds; compounds; compositions; therapy; pharmaceutically
Prior art date: 2002-04-18

Application number

NO20044995A

Other languages

English (en)

Norwegian (no)

Inventor

Eifion Phillips

Hui-Fang Chang

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-18

Filing date

2004-11-17

Publication date

2005-01-18

2002-04-18 Priority claimed from SE0201185A external-priority patent/SE0201185D0/xx

2002-12-04 Priority claimed from SE0203606A external-priority patent/SE0203606D0/xx

2004-11-17 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-01-18 Publication of NO20044995L publication Critical patent/NO20044995L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurosurgery (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20044995A 2002-04-18 2004-11-17 Heterosykliske forbindelser NO20044995L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0201185A SE0201185D0 (sv)	2002-04-18	2002-04-18	Heterocyclic compounds
SE0203606A SE0203606D0 (sv)	2002-12-04	2002-12-04	Heterocyclic compounds
PCT/SE2003/000615 WO2003087104A1 (en)	2002-04-18	2003-04-15	Heterocyclic compounds

Publications (1)

Publication Number	Publication Date
NO20044995L true NO20044995L (no)	2005-01-18

Family

ID=29253787

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044995A NO20044995L (no)	2002-04-18	2004-11-17	Heterosykliske forbindelser

Country Status (17)

Country	Link
US (1)	US7417050B2 (zh)
EP (1)	EP1499616B1 (zh)
JP (1)	JP4523775B2 (zh)
KR (1)	KR20040099446A (zh)
CN (1)	CN1325501C (zh)
AT (1)	ATE433981T1 (zh)
AU (1)	AU2003224546B2 (zh)
BR (1)	BR0309345A (zh)
CA (1)	CA2482313A1 (zh)
DE (1)	DE60328010D1 (zh)
ES (1)	ES2326638T3 (zh)
HK (1)	HK1080470B (zh)
IL (1)	IL164511A0 (zh)
MX (1)	MXPA04010190A (zh)
NO (1)	NO20044995L (zh)
NZ (1)	NZ561993A (zh)
WO (1)	WO2003087104A1 (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR036040A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
WO2003029252A1 (en)	2001-10-02	2003-04-10	Pharmacia & Upjohn Company	Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
JP4130466B2 (ja)	2003-08-01	2008-08-06	田辺三菱製薬株式会社	新規化合物
US8785403B2 (en)	2003-08-01	2014-07-22	Mitsubishi Tanabe Pharma Corporation	Glucopyranoside compound
WO2005030778A1 (en) *	2003-09-25	2005-04-07	Astrazeneca Ab	Ligands
NZ546413A (en) *	2003-10-21	2009-12-24	Astrazeneca Ab	Spirofuropyridine aryl ligands for nicotinic acetylcholine receptors and their use in therapy
US7045530B2 (en)	2003-12-22	2006-05-16	Abbott Laboratories	Spirocyclic quinuclidinic ether derivatives
TW200813067A (en) *	2006-05-17	2008-03-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
UY30730A1 (es)	2006-12-04	2008-07-03	Mitsubishi Tanabe Pharma Corp	Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
NO2200606T3 (zh)	2007-09-10	2018-03-24
CL2008003653A1 (es)	2008-01-17	2010-03-05	Mitsubishi Tanabe Pharma Corp	Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
ES2325049B2 (es) *	2008-02-21	2010-03-16	Universidade De Santiago De Compostela	Deteccion y cuantificacion de iminas ciclicas basada en la union competitiva a receptores nicotinicos de acetilcolina.
US20110160184A1 (en)	2008-06-20	2011-06-30	Astrazeneca Ab	Dibenzothiazepine Derivatives and Use Thereof
US9056850B2 (en)	2008-10-17	2015-06-16	Janssen Pharmaceutica N.V.	Process for the preparation of compounds useful as inhibitors of SGLT
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
US20110009347A1 (en)	2009-07-08	2011-01-13	Yin Liang	Combination therapy for the treatment of diabetes
BR112012008939B1 (pt)	2009-10-14	2021-06-22	Janssen Pharmaceutica Nv	Processo para a preparação de compostos úteis como inibidores de sglt2
MX339570B (es)	2010-05-11	2016-05-31	Janssen Pharmaceutica Nv	Formulaciones farmaceuticas que comprenden derivados de 1-(beta-d-glucopiranosil)-2-tienil-metilbenceno como inhibidores de transportadores de glucosa dependientes de sodio.
SG185594A1 (en)	2010-05-17	2012-12-28	Envivo Pharmaceuticals Inc	A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
DK2697218T3 (en)	2011-04-13	2016-07-25	Janssen Pharmaceutica Nv	PROCESS FOR THE PREPARATION OF COMPOUNDS useful as inhibitors of SGLT2
US9035044B2 (en)	2011-05-09	2015-05-19	Janssen Pharmaceutica Nv	L-proline and citric acid co-crystals of (2S, 3R, 4R, 5S,6R)-2-(3-((5-(4-fluorophenyl)thiopen-2-yl)methyl)4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
RU2017136693A (ru)	2012-05-08	2019-02-08	Форум Фармасьютикалз, Инк.	Способы поддержания, лечения или улучшения когнитивной функции
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
WO2014122474A1 (en)	2013-02-07	2014-08-14	Takeda Pharmaceutical Company Limited	Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
CA2914263C (en)	2013-06-21	2021-05-18	Takeda Pharmaceutical Company Limited	1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
US20170071970A1 (en)	2015-09-15	2017-03-16	Janssen Pharmaceutica Nv	Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR013184A1 (es)	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) *	1999-01-15	1999-01-15	Astra Ab	New compounds
FR2788982B1 (fr) *	1999-02-02	2002-08-02	Synthelabo	Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
US6569865B2 (en) *	2001-06-01	2003-05-27	Astrazeneca Ab	Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
DK1397366T3 (da)	2001-06-01	2007-05-07	Astrazeneca Ab	Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi

2003
- 2003-04-15 JP JP2003584060A patent/JP4523775B2/ja not_active Expired - Fee Related
- 2003-04-15 CN CNB038139014A patent/CN1325501C/zh not_active Expired - Fee Related
- 2003-04-15 CA CA002482313A patent/CA2482313A1/en not_active Abandoned
- 2003-04-15 WO PCT/SE2003/000615 patent/WO2003087104A1/en active Application Filing
- 2003-04-15 EP EP03721209A patent/EP1499616B1/en not_active Expired - Lifetime
- 2003-04-15 AT AT03721209T patent/ATE433981T1/de not_active IP Right Cessation
- 2003-04-15 ES ES03721209T patent/ES2326638T3/es not_active Expired - Lifetime
- 2003-04-15 BR BR0309345-0A patent/BR0309345A/pt not_active IP Right Cessation
- 2003-04-15 US US10/511,525 patent/US7417050B2/en not_active Expired - Fee Related
- 2003-04-15 AU AU2003224546A patent/AU2003224546B2/en not_active Ceased
- 2003-04-15 NZ NZ561993A patent/NZ561993A/en unknown
- 2003-04-15 MX MXPA04010190A patent/MXPA04010190A/es active IP Right Grant
- 2003-04-15 KR KR10-2004-7016545A patent/KR20040099446A/ko not_active Application Discontinuation
- 2003-04-15 DE DE60328010T patent/DE60328010D1/de not_active Expired - Lifetime
2004
- 2004-10-11 IL IL16451104A patent/IL164511A0/xx unknown
- 2004-11-17 NO NO20044995A patent/NO20044995L/no not_active Application Discontinuation
2006
- 2006-01-06 HK HK06100288.5A patent/HK1080470B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2326638T3 (es)	2009-10-16
CN1662542A (zh)	2005-08-31
EP1499616A1 (en)	2005-01-26
NZ561993A (en)	2008-09-26
HK1080470A1 (en)	2006-04-28
ATE433981T1 (de)	2009-07-15
US20050131003A1 (en)	2005-06-16
MXPA04010190A (es)	2005-02-03
US7417050B2 (en)	2008-08-26
IL164511A0 (en)	2005-12-18
HK1080470B (zh)	2008-03-07
WO2003087104A1 (en)	2003-10-23
KR20040099446A (ko)	2004-11-26
CA2482313A1 (en)	2003-10-23
BR0309345A (pt)	2005-02-15
CN1325501C (zh)	2007-07-11
JP2005534624A (ja)	2005-11-17
EP1499616B1 (en)	2009-06-17
DE60328010D1 (de)	2009-07-30
AU2003224546B2 (en)	2008-11-06
AU2003224546A1 (en)	2003-10-27
JP4523775B2 (ja)	2010-08-11

Publication	Publication Date	Title
NO20044995L (no)	2005-01-18	Heterosykliske forbindelser
DE60334536D1 (de)	2010-11-25	Furylverbindungen
ATE477256T1 (de)	2010-08-15	Thienylverbindungen
SE0202463D0 (sv)	2002-08-14	Novel compounds
SE0401971D0 (sv)	2004-08-02	Piperidne derivatives
IS7721A (is)	2005-03-01	Píperidín-pýrídasón og þalasón sem PDE4 hemlar
ATE302775T1 (de)	2005-09-15	Carbolinderivate
CY1110498T1 (el)	2015-04-29	Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα
ATE553106T1 (de)	2012-04-15	Heteroarylpyrrolopyridinone als kinaseinhibitoren
SE0401970D0 (sv)	2004-08-02	Novel compounds
ATE346067T1 (de)	2006-12-15	Carbolinderivate
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
SE0203303D0 (sv)	2002-11-07	Novel Compounds
SE0203300D0 (sv)	2002-11-07	Novel Compounds
ATE419242T1 (de)	2009-01-15	Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
SE0300105D0 (sv)	2003-01-16	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0203302D0 (sv)	2002-11-07	Novel Compounds
SE0202461D0 (sv)	2002-08-14	Novel compounds
ATE465151T1 (de)	2010-05-15	4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
BRPI0417263A (pt)	2007-03-06	imidazopiridinas para uso como inibidores de secreção gástrica
NO20052994L (no)	2005-07-12	Nye fosforamidderivater.
MXPA06004299A (es)	2006-06-05	Derivados de arilespirofuropiridina.
SE0400285D0 (sv)	2004-02-10	Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
SE0203301D0 (sv)	2002-11-07	Novel Compounds
NO20081818L (no)	2008-06-19	Arylsulfonylkromaner som 5-HT6-inhibitorer - indolylmaleimidderivater som protein kinaseinhibitorer

Legal Events

Date	Code	Title	Description
2010-11-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application